Plant natural products: back to the future or into extinction?

Natural product substances have historically served as the most significant source of new leads for pharmaceutical development. However, with the advent of robotics, bioinformatics, high throughput screening (HTS), molecular biology-biotechnology, combinatorial chemistry, in silico (molecular modeling) and other methodologies, the pharmaceutical industry has largely moved away from plant derived natural products as a source for leads and prospective drug candidates. Can, or will, natural products ever recapture the preeminent position they once held as a foundation for drug discovery and development? The challenges associated with development of natural products as pharmaceuticals are illustrated by the Taxol story. Several misconceptions, which constrain utilization of plant natural products, for discovery and development of pharmaceuticals, are addressed to return natural products to the forefront.

[1]  A. Carleton.  OUR FATHERS OF OLD. , 1963, Transactions of the St. John's Hospital Dermatological Society.

[2]  David J Newman,et al.  Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.

[3]  B G Schuster,et al.  A new integrated program for natural product development and the value of an ethnomedical approach. , 2001, Journal of alternative and complementary medicine.

[4]  M. O'Neil-Johnson,et al.  High-throughput method for the production and analysis of large natural product libraries for drug discovery. , 2002, Analytical chemistry.

[5]  T. Langer,et al.  Strategies for efficient lead structure discovery from natural products. , 2006, Current medicinal chemistry.

[6]  K. C. Nicolaou.  Classics in Total Synthesis II: More Targets, Strategies, Methods , 2003 .

[7]  S. Danishefsky,et al.  Small molecule natural products in the discovery of therapeutic agents: the synthesis connection. , 2006, The Journal of organic chemistry.

[8]  Matthias Hamburger,et al.  Natural products in drug discovery –concepts and approaches for tracking bioactivity , 2006 .

[9]  Lu Zeng,et al.  High-throughput analysis of natural product compound libraries by parallel LC-MS evaporative light scattering detection. , 2002, Analytical chemistry.

[10]  J. Rauha,et al.  Natural products in the process of finding new drug candidates. , 2004, Current medicinal chemistry.

[11]  D. Kingston,et al.  Anticancer Agents from Natural Products , 2005 .

[12]  Paul Chamberlain,et al.  Biopharmaceutical production in plants: problems, solutions and opportunities. , 2005, Trends in biotechnology.

[13]  Michael L. Shuler,et al.  Taxol®: science and applications. , 1995 .

[14]  J. van der Greef,et al.  Liquid Chromatography-Mass Spectrometry , 1989 .

[15]  A Ganesan,et al.  Natural products and combinatorial chemistry: back to the future. , 2004, Current opinion in chemical biology.

[16]  Scott A. Snyder,et al.  Classics in total synthesis : targets, strategies, methods , 1996 .

[17]  J. Bruneton.  PHARMACOGNOSY PHYTOCHEMISTRY,, MEDICINAL PLANTS , 1995 .

[18]  Ian Paterson,et al.  The Renaissance of Natural Products as Drug Candidates , 2005, Science.

[19]  Peter Karuso,et al.  Quality, not quantity: the role of natural products and chemical proteomics in modern drug discovery. , 2004, Combinatorial chemistry & high throughput screening.

[20]  T. Claridge.  High-Resolution NMR Techniques in Organic Chemistry , 1999 .

[21]  S. Mann,et al.  Ciba Foundation Symposium , 1997 .

[22]  A. Foucault,et al.  Centrifugal Partition Chromatography , 1994 .

[23]  Lars Bohlin,et al.  Unconventional natural sources for future drug discovery. , 2004, Drug discovery today.

[24]  D. Chadwick,et al.  Secondary metabolites: their function and evolution. , 1992 .

[25]  John Littleton,et al.  Novel approaches to plant drug discovery based on high throughput pharmacological screening and genetic manipulation. , 2005, Life sciences.

[26]  P. J. Todd,et al.  Mass Spectrometry: A Textbook , 2007 .

[27]  Ikhlas A Khan,et al.  Issues related to botanicals. , 2006, Life sciences.

[28]  E. de Rijke,et al.  Analytical separation and detection methods for flavonoids. , 2006, Journal of chromatography. A.

[29]  G. Deng,et al.  Applications of mass spectrometry in early stages of target based drug discovery. , 2006, Journal of pharmaceutical and biomedical analysis.

[30]  Mathias Dunkel,et al.  Natural products: sources and databases. , 2006, Natural product reports.

[31]  Marcy J. Balunas,et al.  Drug discovery from medicinal plants. , 2005, Life sciences.

[32]  H. Kwon,et al.  Chemical genomics with natural products , 2006 .

[33]  Cragg Gm,et al.  Natural products from marine invertebrates and microbes as modulators of antitumor targets. , 2006 .

[34]  Walter A. Korfmacher,et al.  Principles and applications of LC-MS in new drug discovery. , 2005, Drug discovery today.

[35]  George Hill Mathewson Lawrence,et al.  Taxonomy of vascular plants , 1952 .

[36]  Wilson & Wilson's comprehensive analytical chemistry , 1983 .

[37]  F. Koehn,et al.  The evolving role of natural products in drug discovery , 2005, Nature Reviews Drug Discovery.

[38]  A. McPhail,et al.  Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.

[39]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[40]  R. Carlson,et al.  Two-dimensional NMR spectroscopy: applications for chemists and biochemists. , 1987 .

[41]  A. Berthod.  Countercurrent chromatography : the support-free liquid stationary phase , 2002 .